/C O R R E C T I O N -- Ratio Therapeutics Inc./

In the news release, Ratio Therapeutics Enters Strategic Actinium-225 Supply Agreement with PanTera to Support Radiopharmaceutical Development Programs, issued 30-Jun-2026 by Ratio Therapeutics Inc. over PR Newswire, we are advised by the company that changes have been made. The complete,...